Back to search

Article

Lithium carbonate in Amyotrophic Lateral Sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A; protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial.

2022-10-04

Abstract excerpt

<title>Abstract</title> <p>Background Given the large genetic heterogeneity in Amyotrophic Lateral Sclerosis (ALS), it seems likely that genetic subgroups may benefit differently from treatment. An exploratory meta-analysis identified that patients homozygous for the C-allele at SNP rs12608932, a single nucleotide polymorphism in the gene <italic>UNC13A</italic>, had a statistically significant survival benefit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fd700954-aa06-57e6-9fe2-3e7f1987bfc5
DOI
10.21203/rs.3.rs-2125381/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lithium carbonate in Amyotrophic Lateral Sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A; protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial.DOI 10.21203/rs.3.rs-2125381/v1
Select a neighboring publication to make it the new centre.